GlobeNewswire

MBA Hiring is Strong, with 4 in 5 Companies Planning to Hire Graduates in 2018

Dela

MBA Graduates Commanding Salary Premiums

RESTON, Va., June 21, 2018 (GLOBE NEWSWIRE) -- The Graduate Management Admission Council (GMAC) has released its 17th annual survey report, the GMAC 2018 Corporate Recruiters Survey report, and findings indicate that MBA hiring remains strong. Overall, 81 percent of responding companies plan to hire MBA graduates in 2018.

Among all respondents globally, 52 percent of companies plan to increase MBA starting base salaries this year. Around the world MBA graduates continue to command a salary premium relative to direct-from-industry hires and bachelor's degree hires. The projected median base starting salary for recent MBA graduates in the United States in 2018 is US$105,000, compared with US$85,000 for direct-from-industry new hires and US$65,000 for bachelor's degree new hires.

The data reflect a slight decline in projected hiring among US and European employers compared to 2017's hiring plans: 85 percent of responding US companies and 64 percent of European companies plan to hire recent MBA graduates in 2018. Demand for MBA talent is strongest in Asia Pacific, where 90 percent of responding employers plan to make MBA hires in 2018-the same share as last year.

"Over the past several years we have tracked positive trends in hiring of MBA and business master's graduates," said Sangeet Chowfla, GMAC president and CEO. "Graduates are commanding compensation premiums and companies are increasing starting salaries. The softening in the in the intent to hire numbers for the US and Europe reflects the global economic growth numbers we are seeing, and the prevailing political and student mobility issues. In the Asia Pacific region, hiring projections have remained strong. From the overall analysis, we see that MBA hiring overall is strong, but we are seeing the mix shift geographically."

The survey also found that US employers' intent to hire international business school graduates has softened this year. Forty-seven percent of companies plan to or are willing to hire international talent in 2018, down from 55 percent that had such plans in 2017. In comparison, about the same percentage of European employers plan to or are willing to hire international talent in 2018 (65 percent) as 2017 (64 percent).

"This dip in stated intent by US employers to hire international graduates is potentially a response to the changes - or potential changes - to visa and immigration regulations," said Chowfla. "Even though H1-B visa rules haven't yet changed, there is a perception that they might change in the near future, and some employers may be waiting to see what will happen. The jobs market in the US right now is robust, and companies are constantly having to evaluate their prospects and how best to fill their available roles with strong talent." 

Jamie Belinne is Assistant Dean at Bauer College of Business at the University of Houston, and President of the Board of Directors of the MBA Career Services and Employer Alliance (MBA CSEA), which partners with GMAC on the Corporate Recruiters Survey. "The GMAC survey reflects MBA CSEA's recent Recruiting Trends Survey, where 68% of schools indicated a decline in hiring for international full-time MBA students compared to the same time last year," said Belinne. "As a result, many schools are more actively promoting a global job search as well as creating connections with employers in students' home countries."

Additional Findings

Graduates in data analytics are in high demand
Overall, 71 percent of responding employers plan to place recent business school graduates into data analytics roles in 2018. This puts data analytics among the top job functions employers will place new business school graduates into in 2018, alongside business development (74 percent), marketing (70 percent), and finance (69 percent).

For the first time, the survey collected trending data for Master of Data Analytics hiring. Overall, about half of responding companies (52%) plan to hire Master of Data Analytics graduates in 2018, compared with 35 percent that hired them in 2017. The survey found that hiring demand for Master of Data Analytics graduates is strongest among Asia Pacific employers, among whom 62 percent plan to hire in 2018. About half of employers in Europe (50 percent) and Latin America (47 percent) plan to make similar hires.

Employer education assistance on the rise
According to the survey, most US companies (61 percent) offer financial assistance for employee education and talent development. Among those companies, 2 in 3 (66 percent) have increased their budgets for employee education and talent development compared with five years ago.

A new benefit asked about in this year's survey is student loan repayment assistance. Deemed the "hottest employee benefit of 2017" by Forbes, its seen by employers as an effective way to attract and retain top millennial talent. The survey found that nine percent of US companies currently offer it as a part of their overall benefits package.

Internships are path to jobs
The survey finds that most employers plan to bring on MBA interns in 2018. MBA internships are most prevalent in Asia Pacific and the United States, where 65 percent and 62 percent of employers plan to offer them, respectively. Internships continue to be an avenue to jobs for many business school graduates. Internships provide a way to understand a company, the culture and expectations and remain a good opportunity to obtain permanent positions.

Other hiring trends outside the United States - MiMs, Maccs & Mfins

  • The majority of companies outside the United States plan to hire Master in Management (MiM) talent in 2018. Around 7 in 10 companies in Asia Pacific (73 percent), Europe (72 percent), and Latin America (69 percent) plan to hire MiM graduates in 2018. Among US companies, 39 percent plan to hire MiM graduates.
     
  • While hiring projections for Master of Accounting have held steady among European employers, projections among Asia-Pacific employers are notably down in 2018. Forty-four percent of European companies, 43 percent of US companies, 40 percent of Latin American companies, and 37 percent of Asia-Pacific companies plan to hire recent Master of Accounting graduates in 2018. By world region, Latin American companies have the largest increase between their 2017 actual hiring rate (25 percent) and 2018 projected hiring rate (40 percent).
     
  • The hiring outlook for Master of Finance talent is flat among European employers compared with last year, and down slightly among Asia-Pacific and US employers. Two-thirds of Latin American companies (67 percent) plan to hire Master of Finance talent-the greatest share of any world region. Most European companies also plan to hire Master of Finance graduates this year (57 percent).

Since 2001, the GMAC, together with survey partners and MBA Career Services and Employer Alliance (MBA CSEA), has conducted the Corporate Recruiters Survey. The survey provides an overview of current employer hiring demand for MBA and business master's graduates and examines hiring practices and trends by industry and world region. The survey was conducted in February and March 2018, in association with career services offices at 96 participating graduate business schools worldwide. The survey responses were received from 1,066 employers in 42 countries worldwide who work directly with participating business schools.

In July, GMAC will publish a companion report regarding skills sought by employers.

To download the full report, visit gmac.com/corporaterecruiters. For supporting graphics, visit the GMAC News Center.

About GMAC: The Graduate Management Admission Council (GMAC) is a global, non-profit association of leading graduate business schools. Founded in 1953, we are committed to creating solutions for business schools and candidates to better discover, evaluate and connect with each other. We work on behalf of the schools and the graduate management education community, as well as guide candidates on their journey to higher education, to ensure that no talent goes undiscovered.

GMAC provides world-class research, professional development opportunities and assessments for the industry, designed to advance the art and science of admissions. Owned and administered by GMAC, the Graduate Management Admission Test® (GMAT®) is the most widely used graduate business school assessment, recognized by more than 7,000 programs worldwide. Other GMAC assessments include the NMAT by GMAC(TM) exam, for entrance into graduate management programs in India and South Africa, and the Executive Assessment, specifically designed for Executive programs around the world. Our flagship portal for graduate management education resources and information, www.mba.com, receives 14 million visits a year and features the School Search matching tool and Graduate Management Admission Search Service (GMASS), matching candidates and business schools.

GMAC is based in the United States with offices in the United Kingdom, India, and Hong Kong. To learn more about our work, please visit www.gmac.com.

About MBA CSEA: MBA Career Services & Employer Alliance (MBA CSEA) is an 800+ member global alliance of graduate business career management professionals and employers. The organization is the global leader in delivering the tools, developing the relationships and providing the supportive information and services that produce ongoing success for graduate business career services offices and employers. For more information about MBA CSEA, visit: www.mbacsea.org.

About EFMD: The EFMD management development network includes nearly 900 institutional members from academia, business, public service and consultancy across 88 countries worldwide. EFMD offers a range of services, including conferences and seminars around the world, surveys and the dissemination of knowledge, quality improvement and accreditation via EQUIS, EPAS, EOCCS and CLIP, as well as the EDAF mentoring programme and BSIS impact assessment system. For more information about EFMD, please visit www.efmd.org.

MEDIA CONTACT:
Tania Hernandez-Andersen
Sr. Director, Corporate Brand Communications
+1 (703) 668-9638 Office
+1 (571) 294-4059 Mobile
thernandez-andersen@gmac.com

Infographics accompanying this announcement are available at: 

http://resource.globenewswire.com/Resource/Download/d2be6c96-2fe0-477e-b63f-3255ee8017fe

http://www.globenewswire.com/NewsRoom/AttachmentNg/31430a6f-c620-4d45-950b-40cc0e6e3e87

http://www.globenewswire.com/NewsRoom/AttachmentNg/ee3f5eb0-449d-4176-af1f-18d0f1aec5a3

http://www.globenewswire.com/NewsRoom/AttachmentNg/b8a71216-a29c-4539-936c-e5797c94cd1d




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Graduate Management Admission Council via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Corline Biomedical AB offentliggör bokslutskommuniké för räkenskapsåret 201821.2.2019 08:45:00Pressmeddelande

Corline Biomedical AB ("Corline") publicerar härmed bokslutskommuniké för det fjärde kvartalet och räkenskapsåret 2018. Nedan följer en kort sammanfattning. Fullständig bokslutskommuniké finns tillgänglig på Corlines hemsida (www.corline.se) samt som bifogad fil. VD Henrik Nittmar kommenterar "2018 blev ett genombrottsår för Corline då bolaget gick från preklinisk till klinisk fas i utvecklingen av Renaparin® i och med att RENAPAIR 01-studien öppnade för rekrytering. Nu koncentrerar vi utvecklingsresurserna på att planera inför den värdehöjande fas 2- och fas 3-utvecklingen. Jämfört med branschkollegor har Corline en särskilt gynnsam position i och med att bolaget står på flera ben och parallellt arbetar mot lansering tillsammans med kunder inom medicinteknikområdet. Ett spännande 2019 stundar." Väsentliga händelser under det fjärde kvartalet 2018 Den vetenskapliga tidskriften Transplantation publicerar resultat från den prekliniska utvecklingen av Renaparin®. Här visas i stordjursmode

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum